000			02086 a2200661 4500
005			20250515234635.0
264		0	_c20101221
008			201012s 0 0 eng d
022			_a1528-0020
024	7		_a10.1182/blood-2010-03-272765 _2doi
040			_aNLM _beng _cNLM
100	1		_aDornan, David
245	0	0	_aEffect of FCGR2A and FCGR3A variants on CLL outcome. _h[electronic resource]
260			_bBlood _cNov 2010
300			_a4212-22 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xpharmacokinetics
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHumans
650	0	4	_aLeukemia, Lymphocytic, Chronic, B-Cell _xdiagnosis
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPolymorphism, Single Nucleotide _xgenetics
650	0	4	_aPrognosis
650	0	4	_aReceptors, IgG _xgenetics
650	0	4	_aRituximab
650	0	4	_aTreatment Outcome
650	0	4	_aVidarabine _xanalogs & derivatives
700	1		_aSpleiss, Olivia
700	1		_aYeh, Ru-Fang
700	1		_aDuchateau-Nguyen, Guillemette
700	1		_aDufour, Annika
700	1		_aZhi, Jianguo
700	1		_aRobak, Tadeusz
700	1		_aMoiseev, Sergey I
700	1		_aDmoszynska, Anna
700	1		_aSolal-Celigny, Philippe
700	1		_aWarzocha, Krzysztof
700	1		_aLoscertales, Javier
700	1		_aCatalano, John
700	1		_aAfanasiev, Boris V
700	1		_aLarratt, Loree
700	1		_aRossiev, Viktor A
700	1		_aBence-Bruckler, Isabelle
700	1		_aGeisler, Christian H
700	1		_aMontillo, Marco
700	1		_aWenger, Michael K
700	1		_aWeisser, Martin
773	0		_tBlood _gvol. 116 _gno. 20 _gp. 4212-22
856	4	0	_uhttps://doi.org/10.1182/blood-2010-03-272765 _zAvailable from publisher's website
999			_c20043233 _d20043233